U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Gain of Chromosome 9p

MedGen UID:
309199
•Concept ID:
C1517425
•
Cell or Molecular Dysfunction

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGain of Chromosome 9p

Professional guidelines

PubMed

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Rajkumar SV, Kumar SK
Blood Adv 2020 Aug 11;4(15):3509-3519. doi: 10.1182/bloodadvances.2020002218. PMID: 32750129Free PMC Article
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ
Cancer Genet 2020 Jun;244:40-54. Epub 2020 May 1 doi: 10.1016/j.cancergen.2020.04.004. PMID: 32434132
Copy number variations could predict the outcome of bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
Kim M, Lee SH, Kim J, Lee SE, Kim YJ, Min CK
Genes Chromosomes Cancer 2015 Jan;54(1):20-7. Epub 2014 Aug 21 doi: 10.1002/gcc.22213. PMID: 25145975

Recent clinical studies

Etiology

Genomic profile of columnar cell variant of papillary thyroid carcinoma.
Janovitz T, Williamson DFK, Wong KS, Dong F, Barletta JA
Histopathology 2021 Oct;79(4):491-498. Epub 2021 Jun 15 doi: 10.1111/his.14374. PMID: 33783022
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Rajkumar SV, Kumar SK
Blood Adv 2020 Aug 11;4(15):3509-3519. doi: 10.1182/bloodadvances.2020002218. PMID: 32750129Free PMC Article
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.
Buscarlet M, Provost S, Zada YF, Barhdadi A, Bourgoin V, Lépine G, Mollica L, Szuber N, Dubé MP, Busque L
Blood 2017 Aug 10;130(6):753-762. Epub 2017 Jun 27 doi: 10.1182/blood-2017-04-777029. PMID: 28655780
Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J
Int J Lab Hematol 2015 Apr;37(2):181-9. Epub 2014 May 21 doi: 10.1111/ijlh.12257. PMID: 24845343
Chromosomal abnormalities subdivide neuroepithelial tumors into clinically relevant groups.
Hirose Y, Yoshida K
Keio J Med 2006 Jun;55(2):52-8. doi: 10.2302/kjm.55.52. PMID: 16823260

Diagnosis

Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG, Silveira HCS, Júnior JNA, da Silveira RA, Zucca LE, Cárcano FM, Sanches AON, Neder L, Scapulatempo-Neto C, Serrano SV, Jonasch E, Reis RM, Evangelista AF
Int J Mol Sci 2021 Feb 25;22(5) doi: 10.3390/ijms22052265. PMID: 33668731Free PMC Article
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Rajkumar SV, Kumar SK
Blood Adv 2020 Aug 11;4(15):3509-3519. doi: 10.1182/bloodadvances.2020002218. PMID: 32750129Free PMC Article
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ
Cancer Genet 2020 Jun;244:40-54. Epub 2020 May 1 doi: 10.1016/j.cancergen.2020.04.004. PMID: 32434132
Choroid plexus hyperplasia and chromosome 9p gains.
Boxill M, Becher N, Sunde L, Thelle T
Am J Med Genet A 2018 Jun;176(6):1416-1422. Epub 2018 Apr 16 doi: 10.1002/ajmg.a.38697. PMID: 29663640
Cytogenetics of melanoma and nonmelanoma skin cancer.
Carless MA, Griffiths LR
Adv Exp Med Biol 2014;810:160-81. doi: 10.1007/978-1-4939-0437-2_9. PMID: 25207365

Therapy

Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
Wang L, Zehir A, Nafa K, Zhou N, Berger MF, Casanova J, Sadowska J, Lu C, Allis CD, Gounder M, Chandhanayingyong C, Ladanyi M, Boland PJ, Hameed M
Genes Chromosomes Cancer 2016 Jul;55(7):591-600. Epub 2016 May 9 doi: 10.1002/gcc.22362. PMID: 27072194Free PMC Article
Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
Canton AP, Nishi MY, Furuya TK, Roela RA, Jorge AA
Am J Med Genet A 2016 Apr;170A(4):1046-9. Epub 2015 Dec 22 doi: 10.1002/ajmg.a.37521. PMID: 26689153
Copy number variations could predict the outcome of bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
Kim M, Lee SH, Kim J, Lee SE, Kim YJ, Min CK
Genes Chromosomes Cancer 2015 Jan;54(1):20-7. Epub 2014 Aug 21 doi: 10.1002/gcc.22213. PMID: 25145975
Genome-wide analysis of Ollier disease: Is it all in the genes?
Pansuriya TC, Oosting J, Krenács T, Taminiau AH, Verdegaal SH, Sangiorgi L, Sciot R, Hogendoorn PC, Szuhai K, Bovée JV
Orphanet J Rare Dis 2011 Jan 14;6:2. doi: 10.1186/1750-1172-6-2. PMID: 21235737Free PMC Article
Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.
Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR
Cancer Genet Cytogenet 1992 Jul 15;61(2):165-73. doi: 10.1016/0165-4608(92)90082-j. PMID: 1638499

Prognosis

Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG, Silveira HCS, Júnior JNA, da Silveira RA, Zucca LE, Cárcano FM, Sanches AON, Neder L, Scapulatempo-Neto C, Serrano SV, Jonasch E, Reis RM, Evangelista AF
Int J Mol Sci 2021 Feb 25;22(5) doi: 10.3390/ijms22052265. PMID: 33668731Free PMC Article
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Rajkumar SV, Kumar SK
Blood Adv 2020 Aug 11;4(15):3509-3519. doi: 10.1182/bloodadvances.2020002218. PMID: 32750129Free PMC Article
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ, Houldsworth J, Emmadi R, Dyer L, Wolff DJ
Cancer Genet 2020 Jun;244:40-54. Epub 2020 May 1 doi: 10.1016/j.cancergen.2020.04.004. PMID: 32434132
Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J
Int J Lab Hematol 2015 Apr;37(2):181-9. Epub 2014 May 21 doi: 10.1111/ijlh.12257. PMID: 24845343
Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?
Zalatimo O, Zoccoli CM, Patel A, Weston CL, Glantz M
Adv Exp Med Biol 2013;779:267-89. doi: 10.1007/978-1-4614-6176-0_12. PMID: 23288644

Clinical prediction guides

Strong Expression and Amplification of IGF1R in Pleuropulmonary Blastomas.
Vokuhl C, de Leon-Escapini L, Leuschner I
Pediatr Dev Pathol 2017 Nov-Dec;20(6):475-481. Epub 2017 Apr 6 doi: 10.1177/1093526617700945. PMID: 28382840
ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY
World J Gastroenterol 2014 Jan 7;20(1):183-92. doi: 10.3748/wjg.v20.i1.183. PMID: 24415871Free PMC Article
Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?
Zalatimo O, Zoccoli CM, Patel A, Weston CL, Glantz M
Adv Exp Med Biol 2013;779:267-89. doi: 10.1007/978-1-4614-6176-0_12. PMID: 23288644
Genome-wide analysis of Ollier disease: Is it all in the genes?
Pansuriya TC, Oosting J, Krenács T, Taminiau AH, Verdegaal SH, Sangiorgi L, Sciot R, Hogendoorn PC, Szuhai K, Bovée JV
Orphanet J Rare Dis 2011 Jan 14;6:2. doi: 10.1186/1750-1172-6-2. PMID: 21235737Free PMC Article
Molecular changes during the genesis of human gliomas.
Sehgal A
Semin Surg Oncol 1998 Jan-Feb;14(1):3-12. doi: 10.1002/(sici)1098-2388(199801/02)14:1<3::aid-ssu2>3.0.co;2-f. PMID: 9407626

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...